World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
57
Citations
11297
World Ranking
3631
National Ranking
86

Overview

François Spertini is affiliated with the University Hospital of Lausanne in Switzerland. Their research predominantly lies within the field of Medicine, with a particular focus on Immunology and Allergy, Pathology and Forensic Medicine, Dermatology, and Infectious Diseases.

The scientist's work covers a range of topics primarily related to immune and allergic responses. The main topics of their research include:

  • Allergic Rhinitis and Sensitization
  • Systemic Sclerosis and Related Diseases
  • Asthma and Respiratory Diseases
  • Dermatology and Skin Diseases
  • Dermatologic Treatments and Research
  • Inflammatory Myopathies and Dermatomyositis
  • Mast Cells and Histamine

Frequent publication venues for François Spertini's studies include:

  • Lara D. Veeken
  • Frontiers in Immunology
  • Allergologie select
  • Allergo Journal
  • Allergologie

The scientist has contributed to several recent papers, including:

  • Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study (2020), Clinical and Translational Allergy
  • Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis (2020), Annals of Oncology
  • Phenotype of limited cutaneous systemic sclerosis patients with positive anti-topoisomerase I antibodies: data from the EUSTAR cohort (2022), Lara D. Veeken
  • Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic (2020), Allergologie select
  • Safety and immunogenicity of a synthetic nanoparticle-based, T cell priming peptide vaccine against dengue in healthy adults in Switzerland: a double-blind, randomized, vehicle-controlled, phase 1 study (2023), EBioMedicine

Frequent collaborators in François Spertini's research include:

  • Valeria Riccieri
  • Ana Maria Gheorghiu
  • Elise Siegert
  • Marie Vanthuyne
  • Paloma García de la Peña Lefebvre

Best Publications

  • Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.

    Filipe Martins;Filipe Martins;Latifyan Sofiya;Gerasimos P. Sykiotis;Faiza Lamine

  • Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease

    Cem Gabay;Bruno Fautrel;Jürgen Rech;François Spertini

  • Research needs in allergy: an EAACI position paper, in collaboration with EFA

    Nikolaos G Papadopoulos;Ioana Agache;Sevim Bavbek;Beatrice M Bilo

  • MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis

    Jean Bousquet;Holger J. Schünemann;Peter W. Hellings;Sylvie Arnavielhe

  • Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: Results of a phase I trial

    Jean-Marc Fellrath;Alexander Kettner;Nathalie Dufour;Christian Frigerio

  • Phase I malaria vaccine trial with a long synthetic peptide derived from the merozoite surface protein 3 antigen

    Régine Audran;Régine Audran;Michel Cachat;Floriana Lurati;Soe Soe

  • A malaria vaccine that elicits in humans antibodies able to kill Plasmodium falciparum.

    Pierre Druilhe;François Spertini;Daw Soesoe;Giampietro Corradin

  • CXCR3 Internalization Following T Cell-Endothelial Cell Contact: Preferential Role of IFN-Inducible T Cell α Chemoattractant (CXCL11)

    Alain Sauty;Richard A. Colvin;Ludwig Wagner;Sophie Rochat

  • Targeting of Secretory IgA to Peyer’s Patch Dendritic and T Cells after Transport by Intestinal M Cells

    Jacques Rey;Nathalie Garin;François Spertini;Blaise Corthésy

  • Safety of human immunisation with a live-attenuated Mycobacterium tuberculosis vaccine: a randomised, double-blind, controlled phase I trial.

    François Spertini;Régine Audran;Reza Chakour;Olfa Karoui

  • Elevated serum levels of free interleukin-18 in adult-onset Still’s disease

    Charlotte Girard;Jürgen Rech;Michael Brown;Danièle Allali

  • New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.

    Filipe Martins;Filipe Martins;Gerasimos P Sykiotis;Michel Maillard;Montserrat Fraga

  • Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid†

    Bernard R. Lauwerys;Eric Hachulla;François Spertini;Estibaliz Lazaro

  • Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

    Olga De Santis;Régine Audran;Emilie Pothin;Loane Warpelin-Decrausaz

  • Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms

    Luc Reininger;Thierry Berney;Takanori Shibata;Francois Spertini

  • A synthetic malaria vaccine elicits a potent CD8(+) and CD4(+) T lymphocyte immune response in humans. Implications for vaccination strategies.

    José Alejandro López;Christophe Weilenman;Régine Audran;Mario A. Roggero

  • EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.

    O Boyman;C Kaegi;M Akdis;S Bavbek

  • Secretory IgA Possesses Intrinsic Modulatory Properties Stimulating Mucosal and Systemic Immune Responses

    Laurent Favre;François Spertini;Blaise Corthésy

  • Is diet partly responsible for differences in COVID-19 death rates between and within countries?

    Jean Bousquet;Josep M Anto;Guido Iaccarino;Wienczyslawa Czarlewski

  • Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine.

    Denise Nardelli-Haefliger;Floriana Lurati;Daniel Wirthner;François Spertini

Frequent Co-Authors

Giampietro Corradin
Giampietro Corradin University of Lausanne
Peter Schmid-Grendelmeier
Peter Schmid-Grendelmeier University of Zurich
Margitta Worm
Margitta Worm Charité - University Medicine Berlin
Blaise Corthésy
Blaise Corthésy University Hospital of Lausanne
Jean Bousquet
Jean Bousquet University of Montpellier
Marek Jutel
Marek Jutel Wrocław Medical University
Cezmi A. Akdis
Cezmi A. Akdis University of Zurich
Jorg Dieter Seebach
Jorg Dieter Seebach University of Geneva
Thomas Keil
Thomas Keil University of Würzburg
Ludger Klimek
Ludger Klimek Ghent University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in immunology often intersects with healthcare pathways, especially in nursing and specialized care roles. For individuals looking to fast-track their clinical expertise, exploring accelerated NP programs can be a vital step. These programs allow students to transition quickly from RN to Nurse Practitioner roles, broadening their clinical competencies.

For those beginning their journey without a prior nursing background, enrolling in online accelerated nursing programs for non nurses offers a flexible and efficient pathway into the nursing field. This approach is ideal for career changers eager to move into healthcare without extended on-campus commitments.

Once in the nursing profession, advancing to specialized roles such as acute care requires specific certifications. The acute care NP certification equips nurse practitioners with the skills necessary to handle complex patient care in hospital settings, a crucial competency for immunology-related healthcare roles.

Additionally, many students seek the easiest ABSN to get into to obtain their Bachelor of Science in Nursing quickly and begin practical experience. This can be a strategic choice for those aiming to integrate immunology knowledge with foundational nursing skills efficiently.

Best Scientists Citing François Spertini

Trending Scientists

Recently Published Articles